跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,028 条关于
“OSUCCC–James”
全部
1,028
临床试验
297
药物
0
机构
42
资讯
689
12天前
OSUCCC–James Appoints D. Neil Hayes to Lead Precision Cancer Medicine Institute
2年前
First-in-Human Trial Launched for Novel DHODH Inhibitor HOSU-53 in Solid Tumors and Lymphomas
11个月前
Veris Health and Ohio State University Cancer Center Launch Commercial Digital Cancer Care Platform
去年
Genetic Study Uncovers Key Survival Predictors in Black AML Patients
去年
DHODH Inhibitor HOSU-53, Born from Undergraduate Research, Enters Phase I/II Trials for Cancer
5个月前
Ultrasensitive Blood Test HPV-DeepSeek Predicts Recurrence and Survival in HPV-Associated Head and Neck Cancer
17天前
Blood Cancer Treatment Advances Have Saved Nearly 26 Million Years of Life Over 75 Years
去年
TAE Life Sciences and Ohio State University Partner to Advance Boron Neutron Capture Therapy for Cancer Treatment
2个月前
Ohio State Launches Buckeye BioLaunch, an AI-Enabled Center to Accelerate Therapeutic Discovery and Commercialization
去年
Jabez Biosciences Advances Novel DHODH Inhibitor JBZ-001 in Phase 1 Oncology Trial
第 1 页,共 69 页
上一页
下一页